Publications/ Thailand
 |
| Published by Pacific
Bridge Medical |
July 2005 |
| By Ames Gross and Rachel
Weintraub |
|
The Thai Food and Drug Administration (FDA),
under the Ministry of Public Health (MOPH), is responsible for
protecting the health of consumers by ensuring the safety, quality
and efficacy of health products, including food, pharmaceuticals,
medical devices and cosmetics, in Thailand. The FDA has five
main areas of focus: (1) pre-marketing, (2) post-marketing, (3)
product surveillance, (4) product education for the consumer
and (5) cooperation with other health-related agencies. Presently,
the FDA has close to 500 staff members who run the agency, including
pharmacists, nutritionists, lawyers and other health professionals. |
 |
 |
| Published by Pacific
Bridge Medical |
March 1999 |
| By Ames Gross |
|
| Despite the harsh effects of the Asian financial
crisis, pharmaceutical markets in Asia still have a bright future.
Thailand’s pharmaceutical market suffered drops in 1997 and
1998 but renewed consumer demand and increased incomes are helping
rebound the Thai pharmaceutical market growth rate. The Food and
Drug Administration (FDA), under the Ministry of Public Health
(MOPH), is working to revise the regulatory situation for pharmaceuticals
entering the Thai market. The MOPH is making an effort to revise
its drug classification system, regulatory procedures, pricing
and competition controls, marketing regulations, and intellectual
property protections in order to liberalize the market and minimize
corruption. This article discusses the reform trends in Thailand’s
pharmaceutical market that will most likely ease the obstacles
that foreign companies face in this dynamic drug market. |
 |
 |
 |
| Published in Medical
Device & Diagnostic Industry |
January 1997 |
| By Ames Gross |
 |
| As aging populations continue to
expand in Asian nations, governments are keen to revise their
healthcare systems to accommodate this growth. While Thailand’s
medical device market expands, opportunities for U.S. and foreign
medical device manufacturers will continue to flourish. Like
most developed nations, Thailand’s citizens are afflicted
with cancer, strokes, cardiovascular diseases and traffic accidents.
These illnesses and hazards mean that more advanced medical
device technology will be in great demand over the next several
years. This article highlights Thailand’s healthcare
system and spending, as well as the marketing of medical products
in Thailand and new medical device regulations. Recent success
stories by foreign companies in Thailand, including BioWhittaker,
Inc., are also discussed. |
 |
|
| |
Back to Top
|
Asia
China & Hong Kong
India
Indonesia
Japan
Korea
Malaysia
The Philippines
Singapore
Taiwan
Thailand
Vietnam
|